AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$IQV

Sherbet Eric sold $1.2M of IQV

Sherbet Eric (See Remarks) sold 4,446 shares of IQVIA HOLDINGS INC. (IQV) at $278.83 ($1.24M total) on 2026-11-09.

Original reporting
SEC EDGAR · Sherbet Eric
Published Nov 13, 2026, 12:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 12:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$IQV
Bearish
high confidence
Mentioned
$IQV
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IQVBearishLow
01

Why it matters

The disclosed sale adds new information about insider sentiment and may prompt short‑term price adjustments.

02

Market read

First‑time disclosure of a sizable insider sale; modest trading relevance for IQVIA shareholders.

03

What to watch

Potential tax‑loss harvesting or pre‑planned liquidity needs unrelated to company fundamentals.

Relevance 6/10Novelty 7/10Timing: post‑market today

Background

SEC Form 4 filings disclose insider transactions. This filing reports a sale by an IQVIA officer.

Company-level read

Ticker impact

$IQVBearishHigh confidence
Context

Officer Sherbet Eric sold 4,446 IQVIA shares for $1.24 M on 2026‑11‑09 (Form 4 filing).

Expected impact

likely slight downward pressure as the market prices the insider sell.

Evidence & confidence

A 1.2 M sale by an officer is material and disclosed for the first time, indicating potential concerns.

Market effects

Sector

Minimal; the sale does not materially affect the broader healthcare data sector.

Regional

None; the filing is specific to IQVIA and does not influence regional markets.

Global

Low; only relevant to investors tracking IQVIA.

Counterpoint

What could challenge this read

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • Company
    IQVIA Holdings Inc.

    US‑listed provider of health‑care data and analytics (ticker IQV).

  • Officer
    Sherbet Eric

    Company officer who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

IQV insider trading history →

Related articles

$IQVHighAI 8/10

5 revealing analyst questions from IQVIA’s Q3 earnings call

IQVIA reported Q3 revenue of $4.43 billion, beating estimates by 1.5%, with adjusted EPS of $3.34, a 2% beat. The company raised full-year revenue guidance to $17.43 billion. Analysts discussed AI-driven workflows, margin improvements, and clinical bookings during the earnings call. CEO Ari Bousbib highlighted proprietary data and life sciences expertise as key differentiators.

finance.yahoo.com
$IQVMedAI 8/10

IQVIA Holdings Inc (IQV) (Q3 2026) Earnings Call Highlights: Record Bookings, Raised

IQVIA Holdings Inc. reported Q3 2026 earnings with record bookings and raised guidance. Revenue was $4.428B, up 8% YoY, and adjusted EBITDA rose 8.7%. Challenges include FX headwinds and R&D backlog adjustments. Management highlighted AI adoption and strong biotech demand. Full-year 2026 guidance was increased, with revenue expected between $17.35B-$17.5B. No 2027 guidance was provided.

finance.yahoo.com
$IQVHighAI 8/10

What IQVIA (IQV) Said on Its Q3 Earnings Call

IQVIA reported Q3 revenue growth of 6.9% to $1.79B, with organic growth at 4%. AI adoption contributed to commercial and clinical momentum, with 415 AI agents deployed. The company raised its 2026 outlook, expecting revenue of $17.35B-$17.50B and adjusted EPS of $12.90-$13.00. Cash flow from operations was $825M, with free cash flow at $667M.

finance.yahoo.com
$IQVHighAI 9/10

IQVIA (IQV) Q3 2026 Earnings Call Transcript

IQVIA reported Q3 2026 revenue of $4.43B, up 8%, with organic growth at 6%. Adjusted EBITDA grew 8.7% to $1.03B, and adjusted EPS rose 11.3% to $3.34. R&D solutions revenue increased 8.7%, and commercial solutions revenue grew 6.9%. The company raised full-year revenue guidance to $17.35B-$17.5B. AI deployments and emerging biopharma funding growth were highlighted.

fool.com